Cumberland Pharmaceuticals Inc
CPIXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Cumberland Pharmaceuticals Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Mar 20, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| XTX Topco Ltd | 2026-03-31 | 24,006 | $78K | SEC filing |
| NORTHERN TRUST CORP | 2026-03-31 | 19,603 | $63.7K | SEC filing |
| J. Goldman & Co LP | 2026-03-31 | 81,040 | $263K | SEC filing |
| PERCEPTIVE ADVISORS LLC | 2026-03-31 | 196,978 | $640K | SEC filing |
| Marex Group plc | 2026-03-31 | 36,423 | $118K | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 14,607 | $47.5K | SEC filing |
| TWO SIGMA INVESTMENTS, LP | 2026-03-31 | 11,085 | $36K | SEC filing |
| ACADIAN ASSET MANAGEMENT LLC | 2026-03-31 | 44,288 | Not shown | SEC filing |
| BOOTHBAY FUND MANAGEMENT, LLC | 2026-03-31 | 127,694 | $415K | SEC filing |
| STATE STREET CORP | 2026-03-31 | 39,510 | $128K | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 470,696 | $1.53M | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 114,293 | $371K | SEC filing |
| CITADEL ADVISORS LLC | 2026-03-31 | 16,643 | $54.1K | SEC filing |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 2026-03-31 | 163,468 | $531K | SEC filing |
| Caitong International Asset Management Co., Ltd | 2026-03-31 | 2 | $6 | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 3,260 | $10.6K | SEC filing |
| Bank of New York Mellon Corp | 2026-03-31 | 58,458 | $190K | SEC filing |
| BlackRock, Inc. | 2026-03-31 | 56,891 | $185K | SEC filing |
| HUNTINGTON NATIONAL BANK | 2026-03-31 | 1 | $3 | SEC filing |
- Each value is checked against Cumberland Pharmaceuticals Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Cumberland Pharmaceuticals Inc's share price.
- 1 row left out: the value per share it reports is far from Cumberland Pharmaceuticals Inc's share prices on file from around the report date, far from the value most filers reported for that date, or the value of a security already left out, so it may describe another security or share class.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security. Filers with a row left out above, or with no row above to check, are not listed.
- HUNTINGTON NATIONAL BANK: 1 share reported 2025-12-31; 1 share reported 2026-03-31.
- BlackRock, Inc.: 52,577 shares reported 2025-12-31; 56,891 shares reported 2026-03-31.
- Bank of New York Mellon Corp: 72,513 shares reported 2025-12-31; 58,458 shares reported 2026-03-31.
- BRIDGEWAY CAPITAL MANAGEMENT, LLC: 163,468 shares reported 2025-12-31; 163,468 shares reported 2026-03-31.
- CITADEL ADVISORS LLC: 21,957 shares reported 2025-12-31; 16,643 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 107,274 shares reported 2025-12-31; 114,293 shares reported 2026-03-31.
- RENAISSANCE TECHNOLOGIES LLC: 472,163 shares reported 2025-12-31; 470,696 shares reported 2026-03-31.
- STATE STREET CORP: 33,700 shares reported 2025-12-31; 39,510 shares reported 2026-03-31.
- BOOTHBAY FUND MANAGEMENT, LLC: 128,507 shares reported 2025-12-31; 127,694 shares reported 2026-03-31.
- ACADIAN ASSET MANAGEMENT LLC: 44,288 shares reported 2025-12-31; 44,288 shares reported 2026-03-31.
- TWO SIGMA INVESTMENTS, LP: 24,485 shares reported 2025-12-31; 11,085 shares reported 2026-03-31.
- PERCEPTIVE ADVISORS LLC: 341,087 shares reported 2025-12-31; 196,978 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
15 filers have only one report here.
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-18 | Galante Joseph C · Director | Common Stock | A — Grant, award, or other acquisition | +1,800 | SEC filing |
| 2026-03-18 | Jones James · Director | Common Stock | A — Grant, award, or other acquisition | +1,800 | SEC filing |
| 2026-03-18 | Krogulski Kenneth · Director | Common Stock | A — Grant, award, or other acquisition | +4,000 | SEC filing |
| 2026-03-18 | Herman James L · VP and Chief Compliance Office | Options (right to buy) | A — Grant, award, or other acquisition | +2,500 | SEC filing |
| 2026-03-18 | KAZIMI A J · Chairman and CEO | Options (right to buy) | A — Grant, award, or other acquisition | +100,000 | SEC filing |
| 2026-03-18 | Anthony Todd M. · Vice Pres Organizational Dev | Options (right to buy) | A — Grant, award, or other acquisition | +3,000 | SEC filing |
| 2026-03-18 | Bitterman Chris T. · Vice Pres Sales & Marketing | Options (right to buy) | A — Grant, award, or other acquisition | +3,000 | SEC filing |
| 2026-03-18 | Young Caroline · Director | Common Stock | A — Grant, award, or other acquisition | +1,800 | SEC filing |
Showing 8 of 11 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-12-31 | Krogulski Kenneth · Director | Common Stock | L — Small acquisition | +62 | SEC filing |
| 2025-12-31 | Jones James · Director | Common Stock | L — Small acquisition | +7 | SEC filing |
| 2025-12-31 | KAZIMI A J · Chairman and CEO | Common Stock | L — Small acquisition | +7 | SEC filing |
| 2025-12-31 | Young Caroline · Director | Common Stock | L — Small acquisition | +5 | SEC filing |
| 2025-12-30 | Krogulski Kenneth · Director | Common Stock | L — Small acquisition | +54 | SEC filing |
| 2025-12-30 | Young Caroline · Director | Common Stock | L — Small acquisition | +2 | SEC filing |
| 2025-12-30 | Jones James · Director | Common Stock | L — Small acquisition | +8 | SEC filing |
| 2025-12-30 | KAZIMI A J · Chairman and CEO | Common Stock | L — Small acquisition | +8 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.